PARABDRUGS Intraday Analysis...

PARABDRUGS Share Price

Open 8.65 Change Price %
High 8.90 1 Day 0.00 0.00
Low 8.65 1 Week 0.00 0.00
Close 8.80 1 Month -0.25 -2.76
Volume 20466 1 Year 1.75 24.82
52 Week High 10.40
52 Week Low 3.45
PARABDRUGS Important Levels
Resistance 2 9.03
Resistance 1 8.94
Pivot 8.78
Support 1 8.66
Support 2 8.57
NSE INDIA Most Active Stocks
JPASSOCIAT 16.00 -2.74%
UNITECH 6.35 5.83%
TTML 9.60 20.00%
RCOM 38.75 -0.39%
JPINFRATEC 13.10 17.49%
GMRINFRA 15.80 -0.63%
HINDALCO 189.25 2.66%
JINDALSTEL 126.25 0.64%
ICICIBANK 279.10 1.00%
FEDERALBNK 88.05 0.80%
More..
NSE INDIA Top Gainers Stocks
TTML 9.60 20.00%
NEULANDLAB 1095.95 20.00%
JENSONICOL 10.60 19.77%
IVP 160.05 18.91%
LPDC 4.00 17.65%
JPINFRATEC 13.10 17.49%
SOBHA 336.40 15.60%
PANACEABIO 169.95 15.49%
CELESTIAL 28.40 14.75%
DLINKINDIA 141.70 14.32%
More..
NSE INDIA Top Losers Stocks
BIRLACOT 0.05 -50.00%
KSERASERA 0.10 -33.33%
VISESHINFO 0.15 -25.00%
BLUECHIP 0.20 -20.00%
AUSTRAL 0.30 -14.29%
MVL 0.45 -10.00%
MVL 0.45 -10.00%
COMPINFO 51.00 -7.02%
VISUINTL 0.70 -6.67%
HILTON 23.00 -5.93%
More..

Parabolic Drugs Limited (NSE: PARABDRUGS)

PARABDRUGS Technical Analysis 1.5
As on 1st Mar 2017 PARABDRUGS Share Price closed @ 8.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.62 & Sell for SHORT-TERM with Stoploss of 8.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
PARABDRUGS Target for March
1st Target up-side 10
2nd Target up-side 10.84
3rd Target up-side 11.68
1st Target down-side 7.6
2nd Target down-side 6.76
3rd Target down-side 5.92
PARABDRUGS Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
PARABDRUGS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PARABDRUGS Address
PARABDRUGS
N/A
PARABDRUGS Latest News
Balwan Bansal quits Parabolic Drugs Ltd   Equity Bulls   - 16th Feb 15
How BALLET PUMPS could leave you limping or even missing a toe: Soaring ...   Daily Mail   - 09th Feb 15
Richard Branson should give up on space tourism says rocket scientist   Daily Mail   - 02nd Nov 14
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs   MarketWatch   - 26th Jun 14
Parabolic Drugs updates on CDR application   Moneycontrol.com   - 03rd Apr 13
Parabolic Drugs Ltd's CDR Application approved   Equity Bulls   - 02nd Apr 13
Parabolic Drugs a good bet for long-term play   Economic Times   - 03rd Jan 12
Mr. Vineet Gupta, Executive Director, Parabolic Drugs Ltd.   India Infoline.com   - 28th Mar 11
Parabolic Drugs IPO fully subscribed   Moneycontrol.com   - 17th Jun 10
Parabolic Drugs has a limited product   Moneylife Personal Finance Magazine   - 11th Jun 10
Interactive Technical Analysis Chart Parabolic Drugs Limited ( PARABDRUGS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parabolic Drugs Limited
PARABDRUGS Business Profile
Parabolic Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 27.17 crore.The company has reported a standalone sales of Rs 117.12 crore and a Net Loss of Rs 22.32 crore for the quarter ended Sep 2013.The company management includes Pranav Gupta - Chairman & Managing Director, Vineet Gupta - Whole Time Director, Balbir Singh Bhasin - Director, Arun Mathur - Director, Nikhil Goel - Director, Balwan Bansal - Director. It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.Its Registered office is at S.C.O 99-100, Top Floor,,Sector 17 - B Chandigarh,Chandigarh - 160017.Their Registrars are Link Intime India Pvt. Ltd.